CHEMOS
DSPE-PEG2000-Biotin

DSPE-PEG2000-Biotin

DSPE-PEG2000-Biotin•LNP
Structure: DSPE-PEG2000-Biotin structure, CAS 385437-57-0, MW 2000 (Average)
N° produit
CH51053
CAS
385437-57-0
FM
(C2H4O)nC51H93N4O12PS
PM
2000 (Average)
Spécification
Catalog No.CH51053
CAS No.385437-57-0
Molecular Formula(C2H4O)nC51H93N4O12PS
Molecular Weight2000 (Average)

CHEMOS Support for This Category

CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.

Vue d’ensemble

DSPE-PEG2000-Biotin (CAS 385437-57-0, MF (C2H4O)nC51H93N4O12PS, MW 2000 (Average)) is a PEG-lipid conjugate used as a stealth or functional component in nucleic-acid delivery systems. Practical chemistry questions involve PEG repeat distribution, lipid anchor integrity, and terminal-group functionalisation strategy. CHEMOS process-development team and large production base can support route refinement, scale-up and custom synthesis on request.

Applications

  • DSPE-PEG2000-Biotin (CAS 385437-57-0) route review and custom analog preparation
  • Custom synthesis of PEG-lipid analogs with controlled molecular weight
  • Process-development support for scalable PEG-lipid preparation
  • Analytical method development for PEG-lipid characterisation

Besoin d’une synthèse à façon ?

Notre équipe CDMO accompagne la synthèse à façon, de l’évaluation de voie au développement de procédé et au scale-up.

Voir les services CDMO